Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1726 AL 1740

Problems with the present inhibitors and a relevance of new and improved COMT inhibitors in Parkinson's disease

Kaakkola S.

Int Rev Neurobiol. 2010;95:207-25. doi: 10.1016/B978-0-12-381326-8.00009-0.

Preliminary investigation of test-retest reliability of a robotic assessment for Parkinson's disease

Brewer BR, Pradhan S.

Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:5863-6. doi: 10.1109/IEMBS.2010.5627519.

Towards high accuracy classification of MER signals for target localization in Parkinson's disease

Pinzon-Morales RD, Orozco-Gutierrez AA, Carmona-Villada H, Castellanos CG.

Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:4040-3. doi: 10.1109/IEMBS.2010.5628014.

Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial

Troche MS, Okun MS, Rosenbek JC, Musson N, Fernandez HH, Rodriguez R, Romrell J, Pitts T, Wheeler-Hegland KM, Sapienza CM.

Neurology. 2010 Nov 23;75(21):1912-9. doi: 10.1212/WNL.0b013e3181fef115.

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P.

Neurology. 2010 Nov 23;75(21):1920-7. doi: 10.1212/WNL.0b013e3181feb2ab.

Active theater as a complementary therapy for Parkinson's disease rehabilitation: a pilot study

Modugno N, Iaconelli S, Fiorlli M, Lena F, Kusch I, Mirabella G.

ScientificWorldJournal. 2010 Nov 16;10:2301-13. doi: 10.1100/tsw.2010.221.

Discovering neuroprotection in Parkinson's disease, or getting to haphazard

Kieburtz K.

Mt Sinai J Med. 2010 Nov-Dec;77(6):700-6. doi: 10.1002/msj.20219.

Ventricular ectopy following successful cryoablation for Wolff-Parkinson-White syndrome in the right posterior septum: a case report

Rausch CM, Schaffer M, Collins KK.

Congenit Heart Dis. 2010 Nov-Dec;5(6):614-9. doi: 10.1111/j.1747-0803.2010.00397.x.

Tic Disorder: An Unusual Presentation of Neurotoxoplasmosis in a Patient with AIDS

Aquino CC, Felício AC, Godeiro-Junior C, Santos-Neto D, Pedroso JL, Oliveira AS, Silva SM, Borges V, Ferraz HB.

Case Rep Neurol. 2010 Nov 15;2(3):145-149. doi: 10.1159/000322185.

CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes

Schiess MC, Barnes JL, Ellmore TM, Poindexter BJ, Dinh K, Bick RJ.

BMC Neurosci. 2010 Nov 29;11:151. doi: 10.1186/1471-2202-11-151.

Ophthalmological and electrophysiological features of Parkinson's disease

Nowacka B, Lubiński W, Karczewicz D.

Klin Oczna. 2010;112(7-9):247-52.

The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration

Deleidi M, Hallett PJ, Koprich JB, Chung CY, Isacson O.

J Neurosci. 2010 Dec 1;30(48):16091-101. doi: 10.1523/JNEUROSCI.2400-10.2010.

Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease

Black KJ, Koller JM, Campbell MC, Gusnard DA, Bandak SI.

J Neurosci. 2010 Dec 1;30(48):16284-92. doi: 10.1523/JNEUROSCI.2590-10.2010.

[Control of bone remodeling by nervous system. Bone metabolic changes in neurological diseases]

Ishizaki F, Koyama T, Sunayashiki T, Murata Y, Iida T, Harada T.

Clin Calcium. 2010 Dec;20(12):1841-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias